Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death-Reference-Cited by-同舟云学术

Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death

Published:1999-10 Issue:10 Volume:6 Page:1759-1767
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Kügler S,Klöcker N,Kermer P,Isenmann S,Bähr M

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301000.pdf

Reference49 articles.

1. Bergeron L, Yuan J . Sealing one’s fate: control of cell death in neurons Curr Opin Neurobiol 1998 8: 55–63

2. Jacobson MD, Weil M, Raff MC . Programmed cell death in animal development Cell 1997 88: 347–354

3. Strasser A, Huang DC, Vaux DL . The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy Biochim Biophys Acta 1997 1333: 151–178

4. Namura S et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia J Neurosci 1998 18: 3659–3668

5. Barinaga M . Stroke-damaged neurons may commit cellularsuicide Science 1998 281: 1302–1303

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration;Investigative Opthalmology & Visual Science;2022-02-01

2. Gene Therapy Strategies for Glaucomatous Neurodegeneration;Current Gene Therapy;2021-12-23

3. Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats;International Journal of Molecular Sciences;2019-09-03

4. Neuroprotective Strategies in Glaucoma;Current Pharmaceutical Design;2016-04-27

5. Tissue-Specific Promoters in the CNS;Gene Therapy for Neurological Disorders;2016